Jason Volling

Pharmacist
Department of Pharmacy, University Health Network
Toronto, Ontario, Canada

Presentation(s):

• PB1138 - The impact of switching from Anti-Factor Xa (anti-Xa) assays to APTT to monitor intravenous (IV) unfractionated heparin (UFH) at a quaternary care academic centre.

  Tuesday, June 27, 2023
  18:30 – 19:30 ET